Navigation Links
Taking Chemo Drug Continuously Delayed Lung Cancer's Return
Date:6/5/2011

By Amanda Gardner
HealthDay Reporter

SUNDAY, June 5 (HealthDay News) -- While most patients with advanced lung cancer only take four courses of two chemotherapy drugs and then stop until recurrence occurs, continuing treatment with one of those drugs may delay return of the deadly disease, new research suggests.

The results are preliminary, but Spanish scientists report that staying on Alimta (pemextrexed) delayed recurrence of the disease.

"This is the first trial with what looks like a positive outcome where you continue the same treatment," said Dr. Neal Ready, a professor of medicine at the Duke Cancer Institute in Durham, N.C. "All the other positive trials in the past switched chemotherapy regimens, so this is a true 'maintenance' approach" in that doctors maintained the patients on the same drug.

Although overall survival data is not yet in, "if it all bears out and that looks good, this would influence medical oncologists to continue treatment after the standard combination of two chemotherapies at the same time," Ready said.

The findings, which were presented Sunday at the annual meeting of the American Society of Clinical Oncology in Chicago, was funded by Lilly, which makes Alimta.

In this study, almost 1,000 patients with advanced nonsquamous non-small cell lung cancer were given a typical four courses of Alimta and cisplatin. The 539 patients who saw their disease stabilize were then randomly chosen to receive Alimta or a placebo.

Participants taking Alimta lived an average of 4.1 months without a disease recurrence compared to 2.8 months in the placebo group.

"There was a decrease of 38 percent in the risk of progression, which we believe is clinically significant and may support the use of this in a clinical context," said study author Dr. Luis Paz-Ares, chair of oncology at Seville University Hospital in Seville, Spain, who spoke at a Sunday news conference.

Side
'/>"/>

Copyright©2010 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Kids Taking ADHD Drugs at Low Risk for Heart Problems: Study
2. No increase in severe cardiovascular events for children, adolescents taking ADHD medications
3. Taking additional selenium will not reduce cancer risk
4. Women Taking Calcium Supplements May Risk Heart Health, Researchers Say
5. Taking Responsibility for Own Health Often Not Enough
6. Leukemia Patients Taking Gleevec Achieve Normal Death Rate
7. Taking tamoxifen to prevent breast cancer can save lives and money
8. Follow-Up Deemed Lacking for People Taking Opioids
9. Taking Short Breaks From Sitting May Help Waistline and Heart
10. PSA test better predicts cancer in men taking prostate-shrinking drug
11. Patients may not have to stop taking anti-platelets for some surgeries
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Taking Chemo Drug Continuously Delayed Lung Cancer's Return
(Date:1/22/2015)... January 22, 2015 The City of West Hollywood ... a.m., to commemorate the 42nd anniversary of the Supreme Court decision ... “It’s been 42 years since the Roe vs. Wade decision and ... as present as ever,” said City of West Hollywood Councilmember Abbe ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 The Incredible Bulk ... Ben Pakulski to increase lean muscle by up to 30lbs ... caught the attention of HealthyandFitZone.com’s Stan Stevenson, prompting an investigative ... it is a step-by-step, scientific diet formula that allows the ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 Juvent Sports ... at the 2015 PGA Merchandise Show to bestow a ... incredible female amateur golfer, Arlene McKitrick. The award commemorated ... amateur golf tournament win. She won her first amateur ...
(Date:1/22/2015)... Carinsurancesavings.biz has released a new blog post presenting the ... , Purchasing an accidental death and dismemberment rider for ... of rider provides benefits if the insured dies in an ... form of life insurance. , AD&D is not expensive ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 IsoComforter, Inc. has ... machine with patented IsoTube design to treat specific body parts ... the most progressive and easy to use patented cold therapy ... and sports related orthopedic and muscle injuries. IsoComforter has ...
Breaking Medicine News(10 mins):Health News:The Incredible Bulk: Review Examining Ben Pakulski’s Brand New Bulking Muscle Building Diet Program Released 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 3Health News:Accidental Death and Dismemberment Insurance Can Be Purchased at Low Prices Online 2Health News:IsoComforter Introduces Best of Class Cold Therapy Product to the Worldwide Market 2
... The Cystic Fibrosis Foundation announced today that VX-770, an ... in CF, showed promising results in an ongoing Phase ... mutation of CF. The drug is being developed by ... for 14 days showed significant improvements in several key ...
... improved access to health education and benefits for ... seniors in communities across America, ... in Washington, D.C., CVS/pharmacy and the National Council on Aging,(NCOA) ... health and well-being of older Americans. Their joint,"Prescription for Better ...
... Recognizes Visionary Advocate, LOS ANGELES, March 27 ... Gregg Gonsalves has been selected as the,first-ever recipient of ... An AIDS activist for 17 years, Gonsalves has played ... and improve access to,lifesaving drugs. He is currently based ...
... women die from breast cancer each year because current ... fail to stem the disease, warns Breast Cancer Campaign ... research published today, 56 of the UKs most influential ... and priorities for the greatest potential impact on patients. ...
... Poll: Teens Still Feel Targeted By Tobacco Advertising and ... Kids across Virginia,will rally against tobacco on April ... the 13th annual Kick Butts Day, sponsored by the,Campaign ... the,nation (for a list of local events, go to, ...
... VANCOUVER, March 27 /PRNewswire-FirstCall/ - CRH Medical Corporation,(CRM:TSX-V) announced ... in Denver, CO. This Center is the Company,s first ... CRH has targeted for expansion. The,opening of the Denver ... According to the National Institute of Health, the ...
Cached Medicine News:Health News:Cystic Fibrosis Foundation announces positive early results for phase 2 clinical trial of VX-770 2Health News:CVS/pharmacy and the National Council on Aging Extend 'Prescription for Better Health' Partnership 2Health News:CVS/pharmacy and the National Council on Aging Extend 'Prescription for Better Health' Partnership 3Health News:AIDS Activist Gregg Gonsalves Receives $100,000 Leadership Award 2Health News:AIDS Activist Gregg Gonsalves Receives $100,000 Leadership Award 3Health News:Too many women still dying from breast cancer, says charity 2Health News:Virginia Kids 'Kick Butts' on April 2 2Health News:Virginia Kids 'Kick Butts' on April 2 3Health News:CRH Medical Corporation opens new center in Denver, Colorado 2
(Date:1/23/2015)... , Jan. 23, 2015  Now available for sale, The ... support that prevents ankle sprains by cushioning the ankle ... fits securely around the outside of any shoe type ... comfort while still offering protection against sprains. With customers ...
(Date:1/23/2015)... , Jan. 23, 2015  Lixte Biotechnology Holdings, Inc. (OTCQB: ... Phase I trial of Lixte,s lead compound, LB‑100, is being ... John S. Kovach , M.D., the founder and ... to be completed at a single site. Accrual of patients, ...
(Date:1/23/2015)... Africa , Jan. 23, 2015   Leatt Corporation ... personal protective equipment for all forms of sports, including ... Leatt-Brace® neck brace, announced today that the UISP Lega ... now requires all riders to wear a neck brace ...
Breaking Medicine Technology:The Armor1 Ankle Roll Guard is the New Breakthrough Solution for Ankle Sprain Prevention! 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 3Leatt Announces Neck Braces Now Required For Motocross/Minicross Racing In Italy 2Leatt Announces Neck Braces Now Required For Motocross/Minicross Racing In Italy 3
... LONDON, Oct. 5, 2011 SV Life Sciences ("SVLS") today announced ... Dreismann joins SVLS with more than 26 years of experience ... very excited to welcome Dr. Dreismann to SVLS," said Lutz ... team and focus on investments in the diagnostics space. We ...
... EAST BRUNSWICK, N.J., Oct. 5, 2011 Bluestar ... acquisition of property in York, S.C., where it will establish ... Bluestar Silicones will relocate its two U.S. manufacturing ... a 226,000 square foot building set on 20 acres in ...
Cached Medicine Technology:SV Life Sciences Appoints Veteran Diagnostics Professional Dr. Heiner Dreismann as Venture Partner 2Bluestar Silicones Moves Forward with Growth Plans; Completes Acquisition of Facility in South Carolina 2
Neomycin and Polymyxin B sulfates and Dexamethasone ophthalmic ointment is a multiple dose anti-infective steroid combination in sterile ointment form for topical applications....
... version of the Neuro-MEP. Permanent ... certainty. Using of unique ERG-electrodes and ... for lead electrodes fixation. Detailed patients' ... to the patient's age. Input and ...
... Standard 21" is the ... high luminance 21" monitor. It ... well suited for all kinds ... groups. The refractive camera is ...
Cannula and irrigation extension. Overall Length 150 mm (6.25"). Light Curve....
Medicine Products: